Supriya Lifescience declares Q1 FY27 unaudited results

Supriya Lifescience Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results during a meeting held on August 13, 2026. The company submitted the results along with a limited review report from its statutory auditors, Kakaria and Associates LLP. The financial statements were prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) and other applicable accounting principles. The auditors confirmed that based on their review, nothing came to their attention to suggest material misstatements or non-disclosure of required information.